25 XP   0   0   10

Ekso Bionics Holdings Inc
Buy, Hold or Sell?

Let's analyse Ekso Bionics Holdings Inc together

PenkeI guess you are interested in Ekso Bionics Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ekso Bionics Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ekso Bionics Holdings Inc

I send you an email if I find something interesting about Ekso Bionics Holdings Inc.

Quick analysis of Ekso Bionics Holdings Inc (30 sec.)










What can you expect buying and holding a share of Ekso Bionics Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$0.70
Expected worth in 1 year
$-0.01
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.72
Return On Investment
-60.8%

For what price can you sell your share?

Current Price per Share
$1.18
Expected price per share
$0.8787 - $1.49
How sure are you?
50%

1. Valuation of Ekso Bionics Holdings Inc (5 min.)




Live pricePrice per Share (EOD)

$1.18

Intrinsic Value Per Share

$-8.79 - $-5.76

Total Value Per Share

$-8.08 - $-5.06

2. Growth of Ekso Bionics Holdings Inc (5 min.)




Is Ekso Bionics Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.6m$29.8m-$13m-78.1%

How much money is Ekso Bionics Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.7m-$3.6m-$67.7k-1.8%
Net Profit Margin-82.8%-120.0%--

How much money comes from the company's main activities?

3. Financial Health of Ekso Bionics Holdings Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#138 / 169

Most Revenue
#134 / 169

Most Profit
#131 / 169

Most Efficient
#147 / 169

What can you expect buying and holding a share of Ekso Bionics Holdings Inc? (5 min.)

Welcome investor! Ekso Bionics Holdings Inc's management wants to use your money to grow the business. In return you get a share of Ekso Bionics Holdings Inc.

What can you expect buying and holding a share of Ekso Bionics Holdings Inc?

First you should know what it really means to hold a share of Ekso Bionics Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Ekso Bionics Holdings Inc is $1.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ekso Bionics Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ekso Bionics Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.70. Based on the TTM, the Book Value Change Per Share is $-0.18 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ekso Bionics Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-15.2%-0.21-17.8%-0.21-17.8%-0.19-16.1%-0.34-28.4%
Usd Book Value Change Per Share-0.15-12.5%-0.18-15.2%-0.16-13.9%0.032.3%0.021.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.043.5%
Usd Total Gains Per Share-0.15-12.5%-0.18-15.2%-0.16-13.9%0.032.3%0.065.0%
Usd Price Per Share2.50-1.58-1.82-2.97-2.53-
Price to Earnings Ratio-3.48--1.93--2.14--2.85--1.87-
Price-to-Total Gains Ratio-16.88--9.12--11.59--14.86--9.75-
Price to Book Ratio3.55-1.81-1.07--264.48--130.47-
Price-to-Total Gains Ratio-16.88--9.12--11.59--14.86--9.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.18
Number of shares847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.180.03
Usd Total Gains Per Share-0.180.03
Gains per Quarter (847 shares)-151.8223.37
Gains per Year (847 shares)-607.2793.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-607-61709383
20-1215-12240187176
30-1822-18310280269
40-2429-24380374362
50-3036-30450467455
60-3644-36520561548
70-4251-42590654641
80-4858-48660748734
90-5465-54730841827
100-6073-60800935920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%5.035.00.012.5%5.042.00.010.6%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%12.028.00.030.0%14.031.02.029.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.037.07.5%3.00.044.06.4%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%13.027.00.032.5%15.030.02.031.9%

Fundamentals of Ekso Bionics Holdings Inc

About Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.

Fundamental data was last updated by Penke on 2024-04-11 06:46:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ekso Bionics Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ekso Bionics Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -66.3% means that $-0.66 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -66.3%. The company is making a huge loss. -2
  • The TTM is -82.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-66.3%TTM-82.8%+16.5%
TTM-82.8%YOY-120.0%+37.3%
TTM-82.8%5Y-116.1%+33.3%
5Y-116.1%10Y-266.1%+150.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.3%6.2%-72.5%
TTM-82.8%6.4%-89.2%
YOY-120.0%8.0%-128.0%
5Y-116.1%7.3%-123.4%
10Y-266.1%6.8%-272.9%
1.1.2. Return on Assets

Shows how efficient Ekso Bionics Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • -11.1% Return on Assets means that Ekso Bionics Holdings Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ekso Bionics Holdings Inc:

  • The MRQ is -11.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.4%+0.3%
TTM-11.4%YOY-8.9%-2.5%
TTM-11.4%5Y-11.6%+0.1%
5Y-11.6%10Y-17.8%+6.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%1.3%-12.4%
TTM-11.4%1.4%-12.8%
YOY-8.9%1.9%-10.8%
5Y-11.6%2.1%-13.7%
10Y-17.8%2.0%-19.8%
1.1.3. Return on Equity

Shows how efficient Ekso Bionics Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • -25.5% Return on Equity means Ekso Bionics Holdings Inc generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ekso Bionics Holdings Inc:

  • The MRQ is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.5%TTM-22.8%-2.7%
TTM-22.8%YOY-12.2%-10.5%
TTM-22.8%5Y-25.6%+2.8%
5Y-25.6%10Y-55.5%+29.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.5%2.6%-28.1%
TTM-22.8%2.8%-25.6%
YOY-12.2%3.7%-15.9%
5Y-25.6%3.9%-29.5%
10Y-55.5%3.9%-59.4%

1.2. Operating Efficiency of Ekso Bionics Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ekso Bionics Holdings Inc is operating .

  • Measures how much profit Ekso Bionics Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -71.2% means the company generated $-0.71  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ekso Bionics Holdings Inc:

  • The MRQ is -71.2%. The company is operating very inefficient. -2
  • The TTM is -83.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-71.2%TTM-83.6%+12.4%
TTM-83.6%YOY-123.2%+39.6%
TTM-83.6%5Y-127.0%+43.4%
5Y-127.0%10Y-221.9%+94.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-71.2%7.9%-79.1%
TTM-83.6%7.6%-91.2%
YOY-123.2%10.9%-134.1%
5Y-127.0%10.1%-137.1%
10Y-221.9%10.5%-232.4%
1.2.2. Operating Ratio

Measures how efficient Ekso Bionics Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.71 means that the operating costs are $1.71 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 1.712. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.834. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.712TTM1.834-0.123
TTM1.834YOY2.232-0.398
TTM1.8345Y2.245-0.411
5Y2.24510Y3.202-0.957
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7121.152+0.560
TTM1.8341.146+0.688
YOY2.2321.082+1.150
5Y2.2451.097+1.148
10Y3.2021.056+2.146

1.3. Liquidity of Ekso Bionics Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.49 means the company has $2.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 2.490. The company is able to pay all its short-term debts. +1
  • The TTM is 2.670. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.490TTM2.670-0.180
TTM2.670YOY5.858-3.189
TTM2.6705Y4.638-1.969
5Y4.63810Y3.735+0.903
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4902.310+0.180
TTM2.6702.339+0.331
YOY5.8582.575+3.283
5Y4.6382.627+2.011
10Y3.7352.623+1.112
1.3.2. Quick Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.76 means the company can pay off $1.76 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 1.760. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.951. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.760TTM1.951-0.191
TTM1.951YOY5.204-3.253
TTM1.9515Y4.096-2.145
5Y4.09610Y3.250+0.846
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7601.105+0.655
TTM1.9511.137+0.814
YOY5.2041.306+3.898
5Y4.0961.430+2.666
10Y3.2501.533+1.717

1.4. Solvency of Ekso Bionics Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ekso Bionics Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ekso Bionics Holdings Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.56 means that Ekso Bionics Holdings Inc assets are financed with 56.4% credit (debt) and the remaining percentage (100% - 56.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 0.564. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.494. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.564TTM0.494+0.070
TTM0.494YOY0.278+0.217
TTM0.4945Y0.507-0.013
5Y0.50710Y0.722-0.215
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5640.357+0.207
TTM0.4940.360+0.134
YOY0.2780.358-0.080
5Y0.5070.365+0.142
10Y0.7220.375+0.347
1.4.2. Debt to Equity Ratio

Measures if Ekso Bionics Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 129.4% means that company has $1.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ekso Bionics Holdings Inc:

  • The MRQ is 1.294. The company is able to pay all its debts with equity. +1
  • The TTM is 0.997. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.294TTM0.997+0.297
TTM0.997YOY0.395+0.602
TTM0.9975Y1.315-0.317
5Y1.31510Y1.755-0.440
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2940.541+0.753
TTM0.9970.561+0.436
YOY0.3950.561-0.166
5Y1.3150.648+0.667
10Y1.7550.669+1.086

2. Market Valuation of Ekso Bionics Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ekso Bionics Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Ekso Bionics Holdings Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -3.48 means the investor is paying $-3.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is -1.643. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.481. Based on the earnings, the company is expensive. -2
  • The TTM is -1.929. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.643MRQ-3.481+1.838
MRQ-3.481TTM-1.929-1.553
TTM-1.929YOY-2.144+0.216
TTM-1.9295Y-2.849+0.920
5Y-2.84910Y-1.870-0.980
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-1.64314.579-16.222
MRQ-3.48116.584-20.065
TTM-1.92917.443-19.372
YOY-2.14422.147-24.291
5Y-2.84920.830-23.679
10Y-1.87025.069-26.939
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is -3.246. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.877. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.937. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.246MRQ-6.877+3.631
MRQ-6.877TTM-2.937-3.940
TTM-2.937YOY-2.221-0.716
TTM-2.9375Y-5.392+2.454
5Y-5.39210Y-3.527-1.865
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-3.2469.822-13.068
MRQ-6.87710.068-16.945
TTM-2.9371.387-4.324
YOY-2.2213.453-5.674
5Y-5.3925.897-11.289
10Y-3.527-0.177-3.350
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ekso Bionics Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 3.55 means the investor is paying $3.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ekso Bionics Holdings Inc:

  • The EOD is 1.676. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.551. Based on the equity, the company is fair priced.
  • The TTM is 1.809. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.676MRQ3.551-1.875
MRQ3.551TTM1.809+1.741
TTM1.809YOY1.072+0.737
TTM1.8095Y-264.483+266.293
5Y-264.48310Y-130.467-134.016
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.6762.398-0.722
MRQ3.5512.753+0.798
TTM1.8092.690-0.881
YOY1.0723.294-2.222
5Y-264.4833.563-268.046
10Y-130.4674.227-134.694
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ekso Bionics Holdings Inc.

3.1. Institutions holding Ekso Bionics Holdings Inc

Institutions are holding 7.863% of the shares of Ekso Bionics Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc2.4525043692500
2023-12-31Essex Investment Management Company, LLC0.88490.0776157655-62858-28.5053
2023-12-31Kent Lake Capital LLC0.79230.13631411581411580
2023-12-31Geode Capital Management, LLC0.552609845500
2023-12-31Renaissance Technologies Corp0.44910.0003800161130016.4445
2023-12-31BlackRock Inc0.311305545300
2023-12-31Strategic Wealth Designers0.29160.019551950928521.7626
2023-09-30Citadel Advisors Llc0.24320433241775169.4131
2023-12-31Compagnie Lombard, Odier SCA0.14030.00122500000
2023-12-31Northern Trust Corp0.140102495900
2023-12-31State Street Corporation0.130102318000
2023-12-31Legato Capital Management LLC0.06760.00391203800
2023-12-31Atria Wealth Solutions, Inc.0.06750.0004120173062.6129
2023-12-31XTX Topco Ltd0.0630.006211225112250
2023-12-31Advisor Group Holdings, Inc.0.041207341-4838-39.7241
2023-12-31SIMPLEX TRADING, LLC0.01670298129810
2023-12-31UBS Group AG0.00510906758512.1622
2023-12-31Group One Trading, LP0.0026046000
2023-12-31Morgan Stanley - Brokerage Accounts0.0020362300483.871
2023-12-31HARBOUR INVESTMENTS, INC.0.00203583504375
Total 6.65570.24541185763+127718+10.8%

3.2. Funds holding Ekso Bionics Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.999303579387420026.1509
2024-02-29AZ Fd1 AZ Allc Tr A-AZ C1.1730.014721000000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.00240.000317945500
2024-02-29Fidelity Extended Market Index0.36720.000365748-319-0.4828
2023-09-30World Impact SICAV Imptt Glbl Eq IEURAcc0.27930.0275000000
2023-12-31Azimut Trend0.19550.04833500000
2024-02-29Fidelity Series Total Market Index0.09270.00011659300
2024-02-29Fidelity Total Market Index0.082901483800
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.07870.00011408500
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.07870.000114085-229300-94.2129
2023-12-31Essex Inv Mgt Micro Cap Growth0.07440.447613316-8693-39.4975
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06780.00051213300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06430.00051150700
2023-12-31Northern Trust Extended Eq Market Idx0.06430.00051150700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05440.00059744180.1851
2023-09-30BlackRock Extended Mkt Composite0.03850689200
2024-02-29DFA US Core Equity 2 I0.03640652165210
2024-03-31BlackRock Extended Equity Market K0.03360.0001601520.0333
2024-02-29Fidelity Nasdaq Composite Index0.03260.0001584300
2024-03-29Dimensional US Core Equity 2 ETF0.02570460500
Total 5.84170.54071045825-157571-15.1%

3.3. Insider Transactions

Insiders are holding 13.5% of the shares of Ekso Bionics Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-17Jerome WongSELL127841
2023-08-17Scott G DavisSELL374461
2023-05-24Steven ShermanSELL456601.44
2023-05-08Jason C JonesSELL34351.57

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ekso Bionics Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.148-0.179+21%-0.164+11%0.028-637%0.018-940%
Book Value Per Share--0.7040.935-25%1.666-58%1.075-34%0.650+8%
Current Ratio--2.4902.670-7%5.858-58%4.638-46%3.735-33%
Debt To Asset Ratio--0.5640.494+14%0.278+103%0.507+11%0.722-22%
Debt To Equity Ratio--1.2940.997+30%0.395+228%1.315-2%1.755-26%
Dividend Per Share----0%-0%-0%0.042-100%
Eps---0.180-0.210+17%-0.211+17%-0.189+6%-0.335+87%
Free Cash Flow Per Share---0.091-0.171+88%-0.205+126%-0.175+92%-0.250+175%
Free Cash Flow To Equity Per Share---0.071-0.166+132%-0.198+177%0.111-164%0.065-210%
Gross Profit Margin--1.6171.570+3%1.575+3%0.883+83%1.139+42%
Intrinsic Value_10Y_max---5.760--------
Intrinsic Value_10Y_min---8.787--------
Intrinsic Value_1Y_max---0.691--------
Intrinsic Value_1Y_min---0.986--------
Intrinsic Value_3Y_max---1.989--------
Intrinsic Value_3Y_min---2.888--------
Intrinsic Value_5Y_max---3.183--------
Intrinsic Value_5Y_min---4.695--------
Market Cap21125658.000-112%44757750.00028255567.575+58%32628399.750+37%53130850.839-16%45374198.491-1%
Net Profit Margin---0.663-0.828+25%-1.200+81%-1.161+75%-2.661+301%
Operating Margin---0.712-0.836+17%-1.232+73%-1.270+79%-2.219+212%
Operating Ratio--1.7121.834-7%2.232-23%2.245-24%3.202-47%
Pb Ratio1.676-112%3.5511.809+96%1.072+231%-264.483+7549%-130.467+3775%
Pe Ratio-1.643+53%-3.481-1.929-45%-2.144-38%-2.849-18%-1.870-46%
Price Per Share1.180-112%2.5001.578+58%1.823+37%2.968-16%2.534-1%
Price To Free Cash Flow Ratio-3.246+53%-6.877-2.937-57%-2.221-68%-5.392-22%-3.527-49%
Price To Total Gains Ratio-7.969+53%-16.883-9.124-46%-11.589-31%-14.855-12%-9.754-42%
Quick Ratio--1.7601.951-10%5.204-66%4.096-57%3.250-46%
Return On Assets---0.111-0.114+3%-0.089-20%-0.116+4%-0.178+60%
Return On Equity---0.255-0.228-11%-0.122-52%-0.256+0%-0.555+118%
Total Gains Per Share---0.148-0.179+21%-0.164+11%0.028-637%0.060-349%
Usd Book Value--12606000.00016738250.000-25%29817750.000-58%19238350.000-34%11631061.950+8%
Usd Book Value Change Per Share---0.148-0.179+21%-0.164+11%0.028-637%0.018-940%
Usd Book Value Per Share--0.7040.935-25%1.666-58%1.075-34%0.650+8%
Usd Dividend Per Share----0%-0%-0%0.042-100%
Usd Eps---0.180-0.210+17%-0.211+17%-0.189+6%-0.335+87%
Usd Free Cash Flow---1627000.000-3052750.000+88%-3676750.000+126%-3130000.000+92%-4473150.000+175%
Usd Free Cash Flow Per Share---0.091-0.171+88%-0.205+126%-0.175+92%-0.250+175%
Usd Free Cash Flow To Equity Per Share---0.071-0.166+132%-0.198+177%0.111-164%0.065-210%
Usd Market Cap21125658.000-112%44757750.00028255567.575+58%32628399.750+37%53130850.839-16%45374198.491-1%
Usd Price Per Share1.180-112%2.5001.578+58%1.823+37%2.968-16%2.534-1%
Usd Profit---3214000.000-3751750.000+17%-3684000.000+15%-3373300.000+5%-5010250.400+56%
Usd Revenue--4847000.0004569750.000+6%3228000.000+50%3261800.000+49%2803223.675+73%
Usd Total Gains Per Share---0.148-0.179+21%-0.164+11%0.028-637%0.060-349%
 EOD+3 -5MRQTTM+23 -11YOY+22 -125Y+17 -1710Y+21 -15

4.2. Fundamental Score

Let's check the fundamental score of Ekso Bionics Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.643
Price to Book Ratio (EOD)Between0-11.676
Net Profit Margin (MRQ)Greater than0-0.663
Operating Margin (MRQ)Greater than0-0.712
Quick Ratio (MRQ)Greater than11.760
Current Ratio (MRQ)Greater than12.490
Debt to Asset Ratio (MRQ)Less than10.564
Debt to Equity Ratio (MRQ)Less than11.294
Return on Equity (MRQ)Greater than0.15-0.255
Return on Assets (MRQ)Greater than0.05-0.111
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Ekso Bionics Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.705
Ma 20Greater thanMa 501.334
Ma 50Greater thanMa 1001.549
Ma 100Greater thanMa 2001.764
OpenGreater thanClose1.160
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets28,918
Total Liabilities16,312
Total Stockholder Equity12,606
 As reported
Total Liabilities 16,312
Total Stockholder Equity+ 12,606
Total Assets = 28,918

Assets

Total Assets28,918
Total Current Assets20,208
Long-term Assets8,710
Total Current Assets
Cash And Cash Equivalents 8,638
Net Receivables 5,645
Inventory 5,050
Other Current Assets 875
Total Current Assets  (as reported)20,208
Total Current Assets  (calculated)20,208
+/-0
Long-term Assets
Property Plant Equipment 2,995
Goodwill 431
Intangible Assets 4,892
Long-term Assets Other 392
Long-term Assets  (as reported)8,710
Long-term Assets  (calculated)8,710
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,117
Long-term Liabilities8,195
Total Stockholder Equity12,606
Total Current Liabilities
Short-term Debt 1,613
Short Long Term Debt 1,250
Accounts payable 1,847
Other Current Liabilities 2,664
Total Current Liabilities  (as reported)8,117
Total Current Liabilities  (calculated)7,374
+/- 743
Long-term Liabilities
Long term Debt 4,832
Capital Lease Obligations 1,086
Long-term Liabilities Other 105
Long-term Liabilities  (as reported)8,195
Long-term Liabilities  (calculated)6,023
+/- 2,172
Total Stockholder Equity
Common Stock15
Retained Earnings -239,145
Accumulated Other Comprehensive Income 156
Other Stockholders Equity 251,580
Total Stockholder Equity (as reported)12,606
Total Stockholder Equity (calculated)12,606
+/-0
Other
Capital Stock15
Cash and Short Term Investments 8,638
Common Stock Shares Outstanding 14,446
Current Deferred Revenue1,993
Liabilities and Stockholders Equity 28,918
Net Debt -1,470
Net Invested Capital 18,688
Net Working Capital 12,091
Property Plant and Equipment Gross 6,151
Short Long Term Debt Total 7,168



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-30
> Total Assets 
5
5
30
29
29
0
0
21,801
18,598
15,418
33,474
30,033
26,906
22,126
32,198
22,551
13,575
21,621
24,425
16,895
18,932
43,405
37,988
30,959
23,208
22,423
17,655
20,860
25,583
20,292
21,915
16,944
22,349
23,486
20,597
56,504
52,973
50,733
49,166
44,242
40,520
39,311
40,903
37,104
33,986
31,183
28,918
28,91831,18333,98637,10440,90339,31140,52044,24249,16650,73352,97356,50420,59723,48622,34916,94421,91520,29225,58320,86017,65522,42323,20830,95937,98843,40518,93216,89524,42521,62113,57522,55132,19822,12626,90630,03333,47415,41818,59821,8010029293055
   > Total Current Assets 
5
5
30
29
29
0
0
18,856
15,306
11,662
29,300
25,550
22,182
17,248
25,201
18,221
9,367
17,574
20,684
13,262
15,301
40,168
34,937
27,937
20,403
19,853
14,967
16,835
22,133
17,034
18,807
14,062
19,910
21,549
18,420
54,605
51,295
49,099
47,795
43,123
39,323
36,754
31,037
27,597
24,720
22,362
20,208
20,20822,36224,72027,59731,03736,75439,32343,12347,79549,09951,29554,60518,42021,54919,91014,06218,80717,03422,13316,83514,96719,85320,40327,93734,93740,16815,30113,26220,68417,5749,36718,22125,20117,24822,18225,55029,30011,66215,30618,8560029293055
       Cash And Cash Equivalents 
5
5
30
29
29
0
0
14,576
10,965
7,176
25,190
21,133
16,251
11,238
19,552
12,314
4,661
12,800
16,846
9,426
10,701
33,439
27,813
20,572
13,890
12,995
7,655
9,236
13,262
8,058
10,872
8,516
13,260
14,549
12,862
49,539
45,938
43,439
40,406
36,176
31,912
29,180
20,525
16,277
13,307
9,937
8,638
8,6389,93713,30716,27720,52529,18031,91236,17640,40643,43945,93849,53912,86214,54913,2608,51610,8728,05813,2629,2367,65512,99513,89020,57227,81333,43910,7019,42616,84612,8004,66112,31419,55211,23816,25121,13325,1907,17610,96514,5760029293055
       Net Receivables 
0
0
0
0
0
0
0
1,775
1,494
1,922
1,549
1,455
2,394
2,185
2,069
2,383
1,606
2,234
1,780
1,282
2,107
2,168
2,760
3,574
3,547
2,988
3,660
3,793
4,541
5,206
5,208
2,658
3,741
4,450
3,389
2,276
2,756
3,121
4,662
3,346
3,341
3,398
4,625
4,827
5,052
5,873
5,645
5,6455,8735,0524,8274,6253,3983,3413,3464,6623,1212,7562,2763,3894,4503,7412,6585,2085,2064,5413,7933,6602,9883,5473,5742,7602,1682,1071,2821,7802,2341,6062,3832,0692,1852,3941,4551,5491,9221,4941,7750000000
       Other Current Assets 
0
0
0
0
0
0
0
407
401
331
388
447
473
726
436
738
692
533
502
689
597
2,097
1,339
958
584
509
281
506
606
428
238
405
525
370
191
636
648
788
485
829
796
668
700
831
759
1,065
875
8751,0657598317006687968294857886486361913705254052384286065062815095849581,3392,0975976895025336927384367264734473883314014070000000
   > Long-term Assets 
0
0
0
0
0
0
0
2,945
3,292
3,756
4,174
4,483
4,724
4,878
6,997
4,330
4,208
4,047
3,741
3,633
3,631
3,237
3,051
3,022
2,805
2,570
2,688
4,025
3,450
3,258
3,108
2,882
2,439
1,937
2,177
1,899
1,678
1,634
1,371
1,119
1,197
2,557
9,866
9,507
9,266
8,821
8,710
8,7108,8219,2669,5079,8662,5571,1971,1191,3711,6341,6781,8992,1771,9372,4392,8823,1083,2583,4504,0252,6882,5702,8053,0223,0513,2373,6313,6333,7414,0474,2084,3306,9974,8784,7244,4834,1743,7563,2922,9450000000
       Property Plant Equipment 
0
0
0
0
0
0
0
1,764
1,840
1,957
2,102
2,183
2,154
2,399
2,625
2,617
2,579
2,561
2,435
2,458
2,562
2,301
2,249
2,350
2,271
2,170
2,365
3,696
3,093
2,897
2,741
2,511
2,133
1,819
1,857
1,664
1,515
1,509
1,207
978
1,069
2,333
3,987
3,682
3,450
3,139
2,995
2,9953,1393,4503,6823,9872,3331,0699781,2071,5091,5151,6641,8571,8192,1332,5112,7412,8973,0933,6962,3652,1702,2712,3502,2492,3012,5622,4582,4352,5612,5792,6172,6252,3992,1542,1832,1021,9571,8401,7640000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
189
0
0
0
0
0
0
0
0
0
431
431
431
431
431
43143143143143100000000018918918918918918918918918918918918918918918918918918918900000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
55
0
0
0
1,584
1,431
1,297
1,162
1,026
894
762
626
491
359
225
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,217
5,136
5,053
4,972
4,892
4,8924,9725,0535,1365,2170000000000000000902253594916267628941,0261,1621,2971,4311,584000550000000000
       Other Assets 
0
0
0
0
0
0
0
1,181
1,451
1,799
2,072
2,300
2,570
2,479
4,372
1,713
1,629
1,486
1,306
1,175
1,069
936
802
124
120
121
134
140
168
172
178
182
117
118
1,005
235
163
125
164
141
128
224
231
0
332
279
0
027933202312241281411641251632351,0051181171821781721681401341211201248029361,0691,1751,3061,4861,6291,7134,3722,4792,5702,3002,0721,7991,4511,1810000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000002,50200000000000000
> Total Liabilities 
10
10
19
14
14
10
16
96,337
36,706
21,340
10,674
10,936
12,971
12,880
23,390
15,798
12,014
13,393
17,894
18,278
17,304
13,738
16,597
16,120
15,582
16,836
14,927
16,326
20,179
13,871
15,118
11,716
22,377
15,085
16,163
15,529
12,877
11,671
11,947
10,756
8,791
10,697
15,461
15,821
16,179
15,926
16,312
16,31215,92616,17915,82115,46110,6978,79110,75611,94711,67112,87715,52916,16315,08522,37711,71615,11813,87120,17916,32614,92716,83615,58216,12016,59713,73817,30418,27817,89413,39312,01415,79823,39012,88012,97110,93610,67421,34036,70696,33716101414191010
   > Total Current Liabilities 
10
10
19
14
14
10
16
5,613
6,105
5,896
6,614
6,708
8,357
8,256
8,619
7,849
5,792
5,506
6,314
7,021
6,587
6,592
9,165
10,028
9,395
10,185
10,132
9,710
9,343
8,087
7,832
7,550
7,129
5,233
4,974
5,981
4,681
4,675
6,855
5,970
4,819
7,858
9,201
9,537
10,129
7,834
8,117
8,1177,83410,1299,5379,2017,8584,8195,9706,8554,6754,6815,9814,9745,2337,1297,5507,8328,0879,3439,71010,13210,1859,39510,0289,1656,5926,5877,0216,3145,5065,7927,8498,6198,2568,3576,7086,6145,8966,1055,61316101414191010
       Short-term Debt 
0
0
18
9
9
9
11
39
40
41
41
42
43
79
80
81
78
67
54
432
972
1,556
2,173
2,367
2,368
2,368
2,333
2,775
2,762
2,768
2,754
2,604
2,702
406
548
1,361
514
372
229
97
51
2,240
2,651
2,972
3,295
1,601
1,613
1,6131,6013,2952,9722,6512,24051972293725141,3615484062,7022,6042,7542,7682,7622,7752,3332,3682,3682,3672,1731,556972432546778818079434241414039119991800
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
41
0
0
0
80
0
0
0
6,843
432
972
1,556
2,139
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,333
2,170
2,433
0
0
814
0
0
0
0
0
1,996
2,310
2,623
2,937
1,250
1,250
1,2501,2502,9372,6232,3101,99600000814002,4332,1702,3332,3332,3332,3332,3332,3332,3332,3332,1391,5569724326,84300080000410000000000
       Accounts payable 
0
0
0
0
0
0
4
1,044
1,227
1,077
783
1,464
2,306
2,148
2,694
3,618
2,074
1,359
1,879
2,867
2,068
990
2,420
3,392
2,590
3,438
3,156
2,474
2,480
1,362
1,903
1,999
1,902
1,813
1,501
1,652
1,428
1,308
3,107
2,939
2,045
2,387
3,151
3,042
3,155
2,502
1,847
1,8472,5023,1553,0423,1512,3872,0452,9393,1071,3081,4281,6521,5011,8131,9021,9991,9031,3622,4802,4743,1563,4382,5903,3922,4209902,0682,8671,8791,3592,0743,6182,6942,1482,3061,4647831,0771,2271,0444000000
       Other Current Liabilities 
10
10
1
0
5
1
1
1,570
1,267
1,323
2,378
1,657
1,976
2,190
1,885
2,928
2,930
2,982
3,556
2,747
2,599
2,804
3,469
2,977
3,127
3,434
3,541
3,250
2,732
2,559
1,683
1,716
1,180
1,566
1,429
1,475
1,317
1,704
2,299
1,819
1,583
2,172
2,278
2,227
2,393
2,096
2,664
2,6642,0962,3932,2272,2782,1721,5831,8192,2991,7041,3171,4751,4291,5661,1801,7161,6832,5592,7323,2503,5413,4343,1272,9773,4692,8042,5992,7473,5562,9822,9302,9281,8852,1901,9761,6572,3781,3231,2671,570115011010
   > Long-term Liabilities 
0
0
18
0
9
9
15
90,724
30,601
15,444
4,060
4,228
4,614
4,624
14,771
7,949
6,222
7,887
11,580
11,257
10,717
7,146
7,432
6,092
6,187
6,651
4,795
6,616
10,836
5,784
7,286
4,166
15,248
9,852
11,189
9,548
8,196
6,996
5,092
4,786
3,972
2,839
6,260
6,284
6,050
8,092
8,195
8,1958,0926,0506,2846,2602,8393,9724,7865,0926,9968,1969,54811,1899,85215,2484,1667,2865,78410,8366,6164,7956,6516,1876,0927,4327,14610,71711,25711,5807,8876,2227,94914,7714,6244,6144,2284,06015,44430,60190,724159901800
       Long term Debt Total 
0
0
0
0
0
0
0
88,162
0
11,908
77
0
0
225
9,195
6,210
4,545
6,165
10,335
0
0
0
0
0
4,874
3,199
2,648
2,105
1,538
972
407
1,788
13,005
7,639
9,112
7,763
6,617
0
0
0
0
0
0
0
0
0
0
00000000006,6177,7639,1127,63913,0051,7884079721,5382,1052,6483,1994,8740000010,3356,1654,5456,2109,195225007711,908088,1620000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000002,50200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
90,613
30,502
15,356
3,983
4,163
4,561
4,624
14,625
7,824
6,114
7,788
4,701
4,730
4,738
1,713
2,546
1,755
2,406
3,425
2,147
3,505
8,364
3,994
6,168
3,571
14,096
6,400
7,881
7,187
6,205
5,004
3,099
2,792
1,863
1,672
0
0
1,842
2,209
0
02,2091,842001,6721,8632,7923,0995,0046,2057,1877,8816,40014,0963,5716,1683,9948,3643,5052,1473,4252,4061,7552,5461,7134,7384,7304,7017,7886,1147,82414,6254,6244,5614,1633,98315,35630,50290,6130000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
2,562
0
3,536
3,983
0
0
4,399
4,613
766
747
822
805
776
653
685
816
766
1,201
1,535
0
36
36
36
36
66
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000663636363601,5351,2017668166856537768058227477664,6134,399003,9833,53602,5620000000
> Total Stockholder Equity
-5
-5
11
0
15
-10
-16
-74,536
-18,109
-5,922
22,800
19,097
13,935
9,246
8,808
6,753
1,561
8,228
6,531
-1,383
1,628
29,667
21,391
14,839
7,626
5,587
2,728
4,534
5,404
6,421
6,797
5,228
-28
8,401
4,434
40,975
40,096
39,062
37,219
33,486
31,729
28,614
25,442
21,283
17,807
15,257
12,606
12,60615,25717,80721,28325,44228,61431,72933,48637,21939,06240,09640,9754,4348,401-285,2286,7976,4215,4044,5342,7285,5877,62614,83921,39129,6671,628-1,3836,5318,2281,5616,7538,8089,24613,93519,09722,800-5,922-18,109-74,536-16-1015011-5-5
   Common Stock
5
5
6
0
6
6
6
78
79
79
102
102
102
102
105
109
16
21
22
22
26
60
60
60
61
63
63
68
75
75
87
6
8
8
8
13
13
13
13
13
13
13
13
13
14
14
15
15141413131313131313131388868775756863636160606026222221161091051021021021027979786660655
   Retained Earnings -239,145-235,931-232,566-228,336-223,947-220,769-216,465-213,487-208,867-206,004-204,046-202,773-199,103-195,127-197,579-185,812-183,278-180,557-180,763-177,697-171,146-167,014-160,031-152,055-144,154-135,176-128,841-123,334-114,861-109,284-100,806-95,042-91,391-86,746-81,561-75,916-71,801-51,646-63,670-119,797-48-42-17-17-13-10-10
   Capital Surplus 
0
0
0
0
0
0
26
45,183
0
45,645
94,499
0
0
95,890
100,094
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
0
0
0
0
0
0
0
0
0
0
0000000000244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686100,09495,8900094,49945,645045,18326000000
   Treasury Stock00000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
18
0
26
26
26
45,183
45,483
45,645
94,499
94,911
95,394
95,890
100,094
101,686
102,341
117,498
121,291
121,880
130,598
165,060
165,825
167,381
167,823
172,721
173,903
182,107
186,142
186,629
189,938
190,811
197,513
203,905
204,376
244,117
244,636
245,299
246,090
246,765
247,347
247,884
248,813
249,237
250,000
250,441
251,580
251,580250,441250,000249,237248,813247,884247,347246,765246,090245,299244,636244,117204,376203,905197,513190,811189,938186,629186,142182,107173,903172,721167,823167,381165,825165,060130,598121,880121,291117,498102,341101,686100,09495,89095,39494,91194,49945,64545,48345,18326262601800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue18,279
Cost of Revenue-8,581
Gross Profit9,6989,698
 
Operating Income (+$)
Gross Profit9,698
Operating Expense-24,810
Operating Income-15,112-15,112
 
Operating Expense (+$)
Research Development5,025
Selling General Administrative10,694
Selling And Marketing Expenses8,472
Operating Expense24,81024,191
 
Net Interest Income (+$)
Interest Income0
Interest Expense-302
Other Finance Cost-0
Net Interest Income-302
 
Pretax Income (+$)
Operating Income-15,112
Net Interest Income-302
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,198-15,026
EBIT - interestExpense = -15,414
-15,198
-14,896
Interest Expense302
Earnings Before Interest and Taxes (EBIT)-15,112-14,896
Earnings Before Interest and Taxes (EBITDA)-13,414
 
After tax Income (+$)
Income Before Tax-15,198
Tax Provision-0
Net Income From Continuing Ops-15,162-15,198
Net Income-15,198
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses33,391
Total Other Income/Expenses Net-86302
 

Technical Analysis of Ekso Bionics Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ekso Bionics Holdings Inc. The general trend of Ekso Bionics Holdings Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ekso Bionics Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ekso Bionics Holdings Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.49 < 1.49 < 1.49.

The bearish price targets are: 1.16 > 1 > 0.8787.

Tweet this
Ekso Bionics Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ekso Bionics Holdings Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ekso Bionics Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ekso Bionics Holdings Inc. The current macd is -0.08780251.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ekso Bionics Holdings Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ekso Bionics Holdings Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ekso Bionics Holdings Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ekso Bionics Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartEkso Bionics Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ekso Bionics Holdings Inc. The current adx is 24.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ekso Bionics Holdings Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Ekso Bionics Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ekso Bionics Holdings Inc. The current sar is 1.43884467.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ekso Bionics Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ekso Bionics Holdings Inc. The current rsi is 38.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Ekso Bionics Holdings Inc Daily Relative Strength Index (RSI) ChartEkso Bionics Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ekso Bionics Holdings Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ekso Bionics Holdings Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Ekso Bionics Holdings Inc Daily Stochastic Oscillator ChartEkso Bionics Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ekso Bionics Holdings Inc. The current cci is -145.85454834.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ekso Bionics Holdings Inc Daily Commodity Channel Index (CCI) ChartEkso Bionics Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ekso Bionics Holdings Inc. The current cmo is -25.24191752.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ekso Bionics Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartEkso Bionics Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ekso Bionics Holdings Inc. The current willr is -89.74358974.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ekso Bionics Holdings Inc Daily Williams %R ChartEkso Bionics Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ekso Bionics Holdings Inc. The current atr is 0.12785745.

Ekso Bionics Holdings Inc Daily Average True Range (ATR) ChartEkso Bionics Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ekso Bionics Holdings Inc. The current obv is 28,269,976.

Ekso Bionics Holdings Inc Daily On-Balance Volume (OBV) ChartEkso Bionics Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ekso Bionics Holdings Inc. The current mfi is 49.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ekso Bionics Holdings Inc Daily Money Flow Index (MFI) ChartEkso Bionics Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ekso Bionics Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Ekso Bionics Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ekso Bionics Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.705
Ma 20Greater thanMa 501.334
Ma 50Greater thanMa 1001.549
Ma 100Greater thanMa 2001.764
OpenGreater thanClose1.160
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ekso Bionics Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on Ekso Bionics Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ekso Bionics Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ekso Bionics Holdings Inc

I send you an email if I find something interesting about Ekso Bionics Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ekso Bionics Holdings Inc.

Receive notifications about Ekso Bionics Holdings Inc in your mailbox!